Apexian Pharmaceuticals, Inc. — Form D

Apexian Pharmaceuticals, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-29. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Mark R KelleyExecutive OfficerIndianapolis, IN
Homer L PearceExecutive OfficerIndianapolis, IN
Steve CarchediDirectorCambridge, MA
Steve CarchediExecutive OfficerCambridge, MA
Timothy R TichenorExecutive OfficerIndianapolis, IN
John R BarnardDirectorIndianapolis, IN
Mark R Kelley, PhDDirectorIndianapolis, IN
Martin R Haslanger, PhDDirectorIndianapolis, IN
Roger R MillerExecutive OfficerIndianapolis, IN
David R BroeckerDirectorIndianapolis, IN
David R BroeckerExecutive OfficerIndianapolis, IN
Richard R MessmannExecutive OfficerIndianapolis, IN
Homer R Pearce, PhDDirectorIndianapolis, IN
David BroeckerDirectorJeffersonville, IN
David BroeckerExecutive OfficerJeffersonville, IN
Homer R PearceDirectorIndianapolis, IN
Mark R Kelly, PhDDirectorIndianapolis, IN
Mark R Kelly, PhDExecutive OfficerIndianapolis, IN
Mark Kelly, PhDDirectorIndianapolis, IN
Mark Kelly, PhDExecutive OfficerIndianapolis, IN
John BarnardDirectorIndianapolis, IN
Homer PearceDirectorIndianapolis, IN
Roger MillerExecutive OfficerIndianapolis, IN
Martin Haslanger, PhDDirectorIndianapolis, IN
Timothy J TichenorExecutive OfficerGrand Rapids, MI

Other filings by this issuer (6)

FiledFormOfferingSold
2019-03-25D$2.0M$150K
2018-07-11D—$2.8M
2016-12-05D$1.5M$1.3M
2016-02-16D$750K$750K
2015-06-24D$650K$275K
2013-06-20D/A$2.5M$2.5M

More